Patent · US Expired

2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1 -hi]indole derivatives useful as antidiabetic agents

US4904684A · kind A · utility

0Cited by

4References

5Claims

0Family size

Assignee

Synthelabo · FR

Inventors

Dennis Bigg · Gif-sur-Yvette, FR
Salomon Langer · Paris, FR
Claude Morel · Massy, FR
Mireille Sevrin · Paris, FR

Key dates

Filing date	Aug 25, 1988
Grant date	Feb 27, 1990
Priority date	—
Expiry date	Aug 25, 2008

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

2-(4,5-Dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole derivatives and their pharmaceutically acceptable salts are useful an antidiabetic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.